Tools
RESEARCH

What the data actually shows.

Notes from our filings database and backtests — published with the numbers, whether they flatter the signals or not.

Browse: Latest (270) · Studies (42) · Explainers (10) · Filing season (7) · Stock audits (211) · Latest filings →

Every non-audit article, newest first — 20 per page.

OCTOBER 16, 2026
Insiders Didn't Sell Ahead of the Non-Reliance 8-K
We checked 129 Item 4.02 filings for insider selling in the 90 days before disclosure. For officers and directors, it ran below the ordinary rate.
Studies · Insiders · 8-K
OCTOBER 15, 2026
A Short-Interest Surge Predicted Nothing
We scored every FINRA short-interest print for 1,624 stocks, 2021–2026: 4,520 biweekly surges of 50% or more. Nothing measurable followed.
Studies · Short interest
OCTOBER 15, 2026
1,227 Lobbying Surges. No Measurable Edge Followed.
After 1,227 quarters where a company at least doubled lobbying spend, the stock, 8-K filings, and next-year contracts matched non-surge quarters.
Studies
OCTOBER 15, 2026
Two Insiders Bought Within Two Weeks
We scored 3,053 buying clusters (2+ insiders in 14 days) from 2025–2026 Form 4 filings. Average: +2.1 points vs the S&P 500 at 63 days. Median: −2.9.
Studies · Insiders
OCTOBER 15, 2026
The Viral 30-Day Insider Recipe, Tested as Written
The viral 30-day insider recipe, run exactly as written on 2025–26 Form 4s: 3,025 clusters, +2.3 pts pooled — but −1.5 in the 2026 holdout.
Studies · Insiders
OCTOBER 15, 2026
A Fails-to-Deliver Spike Predicted Nothing
We scored the SEC's fails-to-deliver spikes for 1,624 stocks, 2021–2026: alone, a spike predicted nothing; with a short-interest spike, stocks trailed.
Studies · Short interest
OCTOBER 15, 2026
Buying What You Oversee Didn't Beat the Market
Of 7,141 disclosed Congress purchases, only 5.7% were inside their own committee jurisdiction — and those trailed the S&P 500.
Studies · Congress
OCTOBER 15, 2026
Insiders Didn't Buy Ahead of the Material 8-K
Insider buying before 2,100 contract filings ran at the ordinary rate (×0.944); before earnings, final-month buying fell to a fifth of mid-cycle pace.
Studies · Insiders · 8-K
OCTOBER 15, 2026
Insiders Sold at Their Usual Rate Before the Leadership 8-K
We checked 3,189 Item 5.02 filings for insider selling in the 90 days before disclosure. It matched the same companies' ordinary rate almost exactly.
Studies · Insiders · 8-K
OCTOBER 15, 2026
No Initiation Drift: New Superinvestor Positions Matched
We scored 40,323 new positions opened by 147 tracked superinvestors from 2016 to 2026. After the filing went public, they matched the S&P 500.
Studies · 13F
OCTOBER 15, 2026
No Activist Drift: 13D and 13G Stocks Trailed the Market
We scored 356 initial 13D and 4,261 initial 13G filings from 2021-2024. Both groups trailed the S&P 500 by about five points in 63 trading days.
Studies
OCTOBER 14, 2026
The Fresh-Plan Sale Barely Exists Anymore
Just 69 of 13,428 Form 144 notices were filed within 90 days of the plan's adoption — and plan age did not predict what the stock did next.
Studies · Insiders
OCTOBER 13, 2026
One Buy in 92 Windows: The Quiet 90 Days Before Large
In the 90 days before 92 large contract starts, overseeing-committee members bought the winner once vs 2.1 expected; all members ran below baseline.
Studies
OCTOBER 13, 2026
The Median Lobbying Dollar Is Followed by $0 in Federal
Five years of lobbying for 863 companies shows no rank correlation with next-year contracts (ρ = −0.003); the median lobbying dollar drew $0.
Studies
OCTOBER 13, 2026
1,404 "Linked" Trades. Chance Predicted 1,385.
Of 2,880 purchases in stocks with lobbying activity, 48.8% were linked to the buyer's committees — almost exactly the 48.1% chance predicts.
Studies
OCTOBER 13, 2026
The Sale Notice That Almost Always Becomes a Sale
We matched 28,040 Form 144 sale notices to Form 4 reports: 83.9% became real sales within 90 days, 90.1% for officers and directors.
Studies
OCTOBER 13, 2026
5.6%: How Rarely Members of Congress Buy What They Oversee
Of 4,205 classifiable purchases by tracked members of Congress, 5.6% fell inside the buyer's own committee jurisdiction — with no sign of an edge.
Studies · Congress
OCTOBER 11, 2026
Fourteen of 33: Where the Insider Buy Never Happened
14 of 33 Filing Tape names show zero insider buys in the parsed Form 4 record; series-wide, 104 buys stand against 15,293 sales.
Studies · Insiders
OCTOBER 11, 2026
Four of 83 Held NVIDIA at $6.59. Nineteen Hold It at $200
NVIDIA rose 30-fold from 2020Q1 to 2026Q2. Holder counts rose with price in-quarter (r = +0.44), but no next-quarter correlation survived.
Studies
OCTOBER 11, 2026
The Median Copycat Portfolio Gained 54%
94 copycat portfolios built from disclosed Congress purchases: the median gained 54% yet trailed the S&P 500 by 25.5 points. Only 20 of 94 beat the index.
Studies

Page 2 of 3: 1 · 2 · 3